The Mechanism by Which Ameliorates Osteoarthritis: A Work Based on Network Pharmacology

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Nov 4

PMID 39494203

Authors

Min-Dong Du

Kai-Yi He

Si-Qi Fan

Jin-Yi Li

Jin-Fu Liu

Zi-Qiang Lei

Gang Qin

Affiliations

Soon will be listed here.

Abstract

Background: (CR) is widely used in traditional Chinese medicine to prevent and treat a variety of diseases. However, its functions and mechanism of action in osteoarthritis (OA) has not been elucidated. Here, a comprehensive strategy combining network pharmacology, molecular docking, molecular dynamics simulation and in vitro experiments was used to address this issue.

Methods: The bioactive ingredients of CR were screened in TCMSP database, and the potential targets of these ingredients were obtained through Swiss Target Prediction database. Genes in OA pathogenesis were collected through GeneCards, OMIM and DisGeNET databases. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were performed using DAVID database. STRING database and Cytoscape 3.10 software were used to construct "component-target-pathway" network, and predict the core targets affected by CR. The binding affinity between bioactive components and the core targets was evaluated by molecular docking and molecular dynamics simulation. The therapeutic activity of kaempferol on chondrocytes in inflammatory conditions was verified by in vitro experiments.

Results: Fifteen CR bioactive ingredients were obtained, targeting 192 OA-related genes. A series of biological processes, cell components, molecular functions and pathways were predicted to be modulated by CR components. The core targets of CR in OA treatment were AKT serine/threonine kinase 1 (AKT1), interleukin 1 beta (IL1B), SRC proto-oncogene, non-receptor tyrosine kinase (SRC), BCL2 apoptosis regulator (BCL2), signal transducer and activator of transcription 3 (STAT3), epidermal growth factor receptor (EGFR), hypoxia-inducible factor 1 subunit alpha (HIF1A), matrix metallopeptidase 9 (MMP9), estrogen receptor 1 (ESR1) and PPARG orthologs from vertebrates (PPARG), and the main bioactive ingredients of CR showed good binding affinity with these targets. In addition, kaempferol, one of the CR bioactive components, weakens the effects of IL-1β on the viability, apoptosis and inflammation of chondrocytes.

Conclusion: Theoretically, CR has great potential to ameliorate the symptoms and progression of OA, via multiple components, multiple targets, and multiple downstream pathways.

References

Gunter B, Butler K, Wallace R, Smith S, Harirforoosh S . Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis. J Clin Pharm Ther. 2016; 42(1):27-38. DOI: 10.1111/jcpt.12484. View

Wang B, Jiang Y, Yao Z, Chen P, Yu B, Wang S . Aucubin Protects Chondrocytes Against IL-1β-Induced Apoptosis In Vitro And Inhibits Osteoarthritis In Mice Model. Drug Des Devel Ther. 2019; 13:3529-3538. PMC: 6791845. DOI: 10.2147/DDDT.S210220. View

Bennell K, Paterson K, Metcalf B, Duong V, Eyles J, Kasza J . Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021; 326(20):2021-2030. PMC: 8611484. DOI: 10.1001/jama.2021.19415. View

Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R . The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2022; 51(D1):D638-D646. PMC: 9825434. DOI: 10.1093/nar/gkac1000. View

Zhuang Z, Ye G, Huang B . Kaempferol Alleviates the Interleukin-1β-Induced Inflammation in Rat Osteoarthritis Chondrocytes via Suppression of NF-κB. Med Sci Monit. 2017; 23:3925-3931. PMC: 5566200. DOI: 10.12659/msm.902491. View

Xue H, Tu Y, Ma T, Liu X, Wen T, Cai M . Lactoferrin Inhibits IL-1β-Induced Chondrocyte Apoptosis Through AKT1-Induced CREB1 Activation. Cell Physiol Biochem. 2015; 36(6):2456-65. DOI: 10.1159/000430206. View

Burley S, Bhikadiya C, Bi C, Bittrich S, Chao H, Chen L . RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning. Nucleic Acids Res. 2022; 51(D1):D488-D508. PMC: 9825554. DOI: 10.1093/nar/gkac1077. View

Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M . The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014; 73(7):1323-30. DOI: 10.1136/annrheumdis-2013-204763. View

Wang Y, Xiao J, Suzek T, Zhang J, Wang J, Zhou Z . PubChem's BioAssay Database. Nucleic Acids Res. 2011; 40(Database issue):D400-12. PMC: 3245056. DOI: 10.1093/nar/gkr1132. View

10.

Ma L, Zhao X, Liu Y, Wu J, Yang X, Jin Q . Dihydroartemisinin attenuates osteoarthritis by inhibiting abnormal bone remodeling and angiogenesis in subchondral bone. Int J Mol Med. 2021; 47(3). PMC: 7846423. DOI: 10.3892/ijmm.2021.4855. View

11.

Feng W, Liu K, Zhang J, Li Y, Liu J, Lu J . [Study on mechanism of Rehmanniae Radix Praeparata for treatment of osteoarthritis based on network pharmacology and molecular docking]. Zhongguo Zhong Yao Za Zhi. 2022; 47(19):5336-5343. DOI: 10.19540/j.cnki.cjcmm.20220427.401. View

12.

Kamala A, Middha S, Karigar C . Plants in traditional medicine with special reference to L.: a review. 3 Biotech. 2018; 8(7):309. PMC: 6037646. DOI: 10.1007/s13205-018-1328-6. View

13.

Lv S, Wang X, Jin S, Shen S, Wang R, Tong P . Quercetin mediates TSC2-RHEB-mTOR pathway to regulate chondrocytes autophagy in knee osteoarthritis. Gene. 2022; 820:146209. DOI: 10.1016/j.gene.2022.146209. View

14.

Jiang R, Hao P, Yu G, Liu C, Yu C, Huang Y . Kaempferol protects chondrogenic ATDC5 cells against inflammatory injury triggered by lipopolysaccharide through down-regulating miR-146a. Int Immunopharmacol. 2019; 69:373-381. DOI: 10.1016/j.intimp.2019.02.014. View

15.

Sun K, Luo J, Guo J, Yao X, Jing X, Guo F . The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020; 28(4):400-409. DOI: 10.1016/j.joca.2020.02.027. View

16.

Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M . GeneCards Version 3: the human gene integrator. Database (Oxford). 2010; 2010:baq020. PMC: 2938269. DOI: 10.1093/database/baq020. View

17.

Zhang J, Fan F, Liu A, Zhang C, Li Q, Zhang C . Icariin: A Potential Molecule for Treatment of Knee Osteoarthritis. Front Pharmacol. 2022; 13:811808. PMC: 9037156. DOI: 10.3389/fphar.2022.811808. View

18.

Wang F, Song X, Ma S, Liu C, Sun X, Wang X . The treatment role of L. to triple-negative breast cancer cells. Biosci Rep. 2019; 39(6). PMC: 6554218. DOI: 10.1042/BSR20190502. View

19.

He L, Pan Y, Yu J, Wang B, Dai G, Ying X . Decursin alleviates the aggravation of osteoarthritis via inhibiting PI3K-Akt and NF-kB signal pathway. Int Immunopharmacol. 2021; 97:107657. DOI: 10.1016/j.intimp.2021.107657. View

20.

Seeliger D, de Groot B . Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 2010; 24(5):417-22. PMC: 2881210. DOI: 10.1007/s10822-010-9352-6. View